NCT03778320View on ClinicalTrials.gov

A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 14, 2018

Primary Completion Date

December 23, 2018

Study Completion Date

January 31, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

CTP-692

Single oral dose

DRUG

D-Serine

Single oral dose

Trial Locations (1)

5000

CMAX Clinical Research, Adelaide

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT03778320 - A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers | Biotech Hunter | Biotech Hunter